- Analytics
- Market Historical Data
- Stocks Historical Prices
- REGENERON-PHARMACEUTICALS
Regeneron Pharmaceuticals Inc. Stock Price History
Regeneron Pharmaceuticals Inc. Historical Data
You can see 24 days of Regeneron Pharmaceuticals Inc. stock price history to determine the stock opening price for each day, i.e. the price at which the stock first trades at the opening of the exchange on the trading day, the highest price of the day is the highest price traded during that period, and the lowest price is the lowest price traded during that period and the closing price, i.e. the last price at which Regeneron Pharmaceuticals Inc. stock trades during a normal trading session. In the last column of the table you will see the percentage change - the ratio of today's closing price to the previous one.
About Regeneron Pharmaceuticals Inc. Stocks
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.